Group One Trading, L.P. Vir Biotechnology, Inc. Transaction History

Group One Trading, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$9.14 - $24.62 $258,789 - $697,090	28,314 Added 271.6%	38,739 $362,000
Q2 2023 Aug 09, 2023	BUY	$23.2 - $27.29 $241,860 - $284,498	10,425 New	10,425 $255,000
Q2 2022 Aug 11, 2022	SELL	$19.08 - $26.7 $234,550 - $328,223	-12,293 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$21.19 - $40.01 $10,997 - $20,765	-519 Reduced 4.05%	12,293 $316,000
Q4 2021 Feb 11, 2022	BUY	$30.97 - $54.03 $396,787 - $692,232	12,812 New	12,812 $536,000
Q3 2021 Nov 12, 2021	SELL	$34.9 - $54.54 $398,453 - $622,683	-11,417 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$38.75 - $51.0 $442,408 - $582,267	11,417 New	11,417 $540,000
Q4 2020 Feb 10, 2021	SELL	$25.51 - $43.38 $9,387 - $15,963	-368 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$28.28 - $53.6 $10,407 - $19,724	368 New	368 $13,000

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.